Operation Warp Speed
- All
- News
-
Twitter to Face First Test in Legal Battle With Elon Musk Over Bid for Fast-Track Trial
Twitter will face its first test in the legal battle with Tesla CEO Elon Musk, over his $44 billion (roughly Rs. 3,51,500 crore) takeover of the microblogging service, as the Delaware Court of Chancery will weigh the company's request for a fast-tracked trial. The company says it wants to resolve months of uncertainty for its business as Musk tries...
-
Biden Asked Not To Accept India-Led Proposal At World Trade Body On Covid Vaccine Patents
Four top Republicans Senator on Friday urged US President Joe Biden not to accept a proposal by India and S Africa to the World Trade Organisation to waive anti-Covid vaccine patents to boost its supply.
-
IBM Warns Hackers Targeting COVID-19 Vaccine 'Cold Chain' Supply Process
IBM said in a blog post on Thursday that hackers are targeting companies critical to the distribution of COVID-19 vaccines. The US Cybersecurity and Infrastructure Security Agency reposted the report, warning members of Operation Warp Speed — the US government's national vaccine mission — to be on the lookout.
-
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
-
Covid Vaccine Could Reach First Americans By Mid-December: Top Health Official
US healthcare workers and others recommended for the nation's first COVID-19 inoculations could start getting shots within a day or two of regulatory consent next month, a top official of the government's vaccine development effort said on Sunday.
-
US Signs $1 Billion COVID-19 Vaccine Deal With Johnson & Johnson For 100 Million Doses
The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.
-
Moderna, Pfizer Start Decisive Covid Vaccine Trials, Eye Year-End Launches
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday.
-
US Pharma Firm Moderna's COVID-19 Vaccine Candidate Enters Late-Stage Trial
Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
-
Twitter to Face First Test in Legal Battle With Elon Musk Over Bid for Fast-Track Trial
Twitter will face its first test in the legal battle with Tesla CEO Elon Musk, over his $44 billion (roughly Rs. 3,51,500 crore) takeover of the microblogging service, as the Delaware Court of Chancery will weigh the company's request for a fast-tracked trial. The company says it wants to resolve months of uncertainty for its business as Musk tries...
-
Biden Asked Not To Accept India-Led Proposal At World Trade Body On Covid Vaccine Patents
Four top Republicans Senator on Friday urged US President Joe Biden not to accept a proposal by India and S Africa to the World Trade Organisation to waive anti-Covid vaccine patents to boost its supply.
-
IBM Warns Hackers Targeting COVID-19 Vaccine 'Cold Chain' Supply Process
IBM said in a blog post on Thursday that hackers are targeting companies critical to the distribution of COVID-19 vaccines. The US Cybersecurity and Infrastructure Security Agency reposted the report, warning members of Operation Warp Speed — the US government's national vaccine mission — to be on the lookout.
-
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
-
Covid Vaccine Could Reach First Americans By Mid-December: Top Health Official
US healthcare workers and others recommended for the nation's first COVID-19 inoculations could start getting shots within a day or two of regulatory consent next month, a top official of the government's vaccine development effort said on Sunday.
-
US Signs $1 Billion COVID-19 Vaccine Deal With Johnson & Johnson For 100 Million Doses
The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.
-
Moderna, Pfizer Start Decisive Covid Vaccine Trials, Eye Year-End Launches
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday.
-
US Pharma Firm Moderna's COVID-19 Vaccine Candidate Enters Late-Stage Trial
Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
